Compare CELZ & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CELZ | IMCC |
|---|---|---|
| Founded | 1998 | 1980 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 4.1M |
| IPO Year | 2008 | 2019 |
| Metric | CELZ | IMCC |
|---|---|---|
| Price | $1.88 | $0.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.9K | ★ 51.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,000.00 | N/A |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 22.22 | N/A |
| 52 Week Low | $1.50 | $0.65 |
| 52 Week High | $6.25 | $7.12 |
| Indicator | CELZ | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 46.33 | 47.08 |
| Support Level | $1.76 | $0.65 |
| Resistance Level | $1.96 | $1.55 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 44.08 | 62.50 |
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.